Skip to content

Prognostic models and biomarkers in patients with acute decompensated heart failure admitted to ward

Prognostic models and biomarkers in patients with acute decompensated heart failure admitted to ward - HF on Ward

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON46619
Enrollment
278
Registered
2018-08-03
Start date
2019-01-28
Completion date
Unknown
Last updated
2024-06-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

acute decompensated heart failure acute heart failure

Interventions

None listed

Sponsors

Catharina-ziekenhuis
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: Undergo treatment for ADHF. Aged 18 or above and mentally competent. Capable of understanding the Dutch language.

Exclusion criteria

Exclusion criteria: Patients where follow-up is not possible (e.g. in-hospital mortality or follow-up not taking place at the Catharina Hospital).

Design outcomes

Primary

MeasureTime frame
The main study parameters will be the ELAN-HF score, biomarker levels and clinical data that is collected during study inclusion. The main study endpoints are all-cause mortality and a composite of all-cause mortality and/or first readmission for cardiovascular reasons within 6 months after discharge.

Secondary

MeasureTime frame
Assess the associations between biomarker levels in patients admitted with ADHF and: - cause-specific mortality 6 months after discharge. - recurrent hospitalizations. - QoL outcomes early after discharge and 6 months after discharge. Develop a prognostic model that predicts QoL outcomes for patients that are admitted with acutely decompensated heart failure, based on serial measurements of a panel of biomarkers and clinical variables contained in electronic health records. Assess prognostic value of features extracted from continuous PPG and accelerometer data from the Elan device in patients that are discharged after they have been treated for ADHF. Assess agreement between a Hemodynamics model and the assessment of the degree of decompensation by the cardiologist.

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)